Capecitabine in Metastatic Breast and GI Cancers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Qamar Khan, MD
University of Kansas Cancer Center - CRC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Kansas Cancer Center - Crc
Fairway, Kansas, United States
- St. Catherine Hospital - Central Care Cancer Center
Garden City, Kansas, United States
- Heartland Cancer Center - Central Care Cancer Center
Great Bend, Kansas, United States
- Hays Medical Center Dreiling-Schmidt Cancer Institute
Hays, Kansas, United States
- University of Kansas Cancer Center - West
Kansas City, Kansas, United States
- Olathe Medical Center
Olathe, Kansas, United States
- University of Kansas Cancer Center - Overland Park
Overland Park, Kansas, United States
- Via Christi Cancer Center
Pittsburg, Kansas, United States
- Salina Regional Health
Salina, Kansas, United States
- St. Francis Comprehensive Cancer Center
Topeka, Kansas, United States
- University of Kansas Cancer Center - Westwood
Westwood, Kansas, United States
- Truman Medical Center
Kansas City, Missouri, United States
- University of Kansas Cancer Center - North
Kansas City, Missouri, United States
- University of Kansas Cancer Center - South
Kansas City, Missouri, United States
- University of Kansas Cancer Center - Lee'S Summit
Lee's Summit, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Oct 2015
- Primary completion
- 31 Dec 2022
- Completion
- 31 Dec 2023
- Last update posted
- 20 Dec 2021
- Registered enrollment
- 200
- Registry id
- NCT02595320
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.